U.S. Women’s Health Products and Markets

This report is a comprehensive study of U.S. markets for products related to women’s health. It includes a wide range of information about the diseases and disorders specific to women, the rapidly changing healthcare environment and its impacts on women’s health issues, new and emerging markets for treatments for female-specific diseases and disorders, an analysis of market leadership and competition within significant women’s healthcare categories, a review of emerging therapies, and a study of leading publicly traded and privately held companies that play a prominent role in the market. Markets covered are cancer
management, contraception, incontinence management, infertility management, and the management of menopausal diseases and disorders.

The markets analyzed in this study relate to traditional gender-specific women’s health concerns. Sales figures and estimates for all markets in this report were obtained from company sources, annual reports, financial analysts, and other experts in each market. Forecast information is based on interviews with these same sources, and a thorough analysis of the future growth potential of product categories based on past performance in the marketplace, as well as trends that will influence future sales.

All market figures pertain to the U.S. market, and are expressed in current U.S. dollars at the wholesale level. Market share figures are presented in terms of dollar sales. Market estimates are presented for the years 1997 through 2002. Compound annual growth rates (CAGRs) are computed for the 1997-2002 period. Procedure volumes are supplied for the years 1997 through 2002. Market figures and procedure volumes pertain only to application in the female population, unless otherwise noted.